The S phase of the cell cycle and its perturbation by human cytomegalovirus

Reviews in Medical Virology

Volumn 17, Issue 6, 2007, Pages 423-434

  Bain, Mark ^a   Sinclair, John ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL DIVISION; CYTOMEGALOVIRUS INFECTION; DNA BINDING; DNA REPLICATION; DNA SYNTHESIS; EUKARYOTE; GENE EXPRESSION; HUMAN CYTOMEGALOVIRUS; NONHUMAN; PROTEIN INTERACTION; REVIEW;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; DNA REPLICATION; HOST-PATHOGEN INTERACTIONS; HUMANS; S PHASE; VIRUS REPLICATION;

EID: 36348950198     PISSN: 10529276     EISSN: None     Source Type: Journal    
DOI: 10.1002/rmv.551     Document Type: Review

References (100)

1. Reddehase MJ (ed.). Cytomegaloviruses: Molecular Biology and Immunology. Caister Academic Press: Wymondham; 2005.
2. Dolan A, Cunningham C, Hector RD, et al. Genetic content of wild-type human cytomegalovirus. J Gen Virol 2004; 85: 1301-1312.
3. Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol 2007; 17: 253.
4. Sissons JG, Bain M, Wills MR. Latency and reactivation of human cytomegalovirus. J Infect 2002; 44: 73-77.
5. Reeves MB, MacAry PA, Lehner PJ, et al. Latency, chromatin remodelling, and reactivation of human cytomegalovirus in the dendritic cells of healthy carriers. Proc Natl Acad Sci USA 2005; 102: 4140-4145.
6. Albrecht T, Rapp F. Malignant transformation of hamster embryo fibroblasts following exposure to ultraviolet-irradiated human cytomegalovirus. Virology 1973; 55: 53-61.
7. Boldogh I, Gonczol E, Vaczi L. Transformation of hamster embryonic fibroblast cells by UV-irradiated human cytomegalovirus. Acta Microbiol Acad Sci Hung 1978; 25: 269-275.
8. Harkins L, Volk AL, Samanta M, et al. Specific localisation of human cytomegalovirus nucleic acids and proteins in human colorectal cancer. The Lancet 2002; 360: 1557-1563.
9. Speir E, Modali R, Huang ES, et al. Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 1994; 265: 391-394.
10. Zhou YF, Yu ZX, Wanishsawad C, Shou M, Epstein SE. The immediate early gene products of human cytomegalovirus increase vascular smooth muscle cell migration, proliferation, and expression of PDGF beta-receptor. Biochem Biophys Res Commun 1999; 256: 608-613.
11. Tumilowicz JJ, Gawlik ME, Powell BB, Trentin JJ. Replication of cytomegalovirus in human arterial smooth muscle cells. J Virol 1985; 56: 839-845.
12. Adam E, Melnick JR, Probtsfield JL, et al. High levels of cytomegalovirus antibody in patients requiring vascular surgery for atherosclerosis. Lancet 1987; 2: 291-293.
13. Takeda DY, Dutta A. DNA replication and progression through S phase. Oncogene 2005; 24: 2827-2843.
14. Sidorova JM, Breeden LL. Precocious G1/S transitions and genomic instability: the origin connection. Mutat Res 2003; 532: 5-19.
15. Harbour JW, Dean DC. The Rb/E2F pathway: expanding roles and emerging paradigms. Genes Dev 2000; 14: 2393-2409.
16. Giacinti C, Giordano A. RB and cell cycle progression. Oncogene 2006; 25: 5220-5227.
17. Zhu L, van den Heuvel S, Helin K, et al. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev 1993; 7: 1111-1125.
18. Brehm A, Miska EA, McCance DJ, et al. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 1998; 391: 597-601.
19. Luo RX, Postigo AA, Dean DC. Rb interacts with histone deacetylase to repress transcription. Cell 1998; 92: 463-473.
20. Magnaghi-Jaulin L, Groisman R, Naguibneva I, et al. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 1998; 391: 601-605.
21. Zhang HS, Gavin M, Dahiya A, et al. Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 2000; 101: 79-89.
22. Johnson DG, Schwarz JK, Cress WD, Nevins JR. Expression of transcription factor E2F1 induces quiescent cells to enter S phase. Nature 1993; 365: 349-352.
23. DeGregori J, Kowalik T, Nevins JR. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol Cell Biol 1995; 15: 4215-4224.
24. Pardee AB, Li CJ, Reddy GP. Regulation in S phase by E2F. Cell Cycle 2004; 3: 1091-1094.
25. Dimova DK, Dyson NJ. The E2F transcriptional network: old acquaintances with new faces. Oncogene 2005; 24: 2810-2826.
26. Blake MC, Azizkhan JC. Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol Cell Biol 1989; 9: 4994-5002.
27. Yan Z, DeGregori J, Shohet R, et al. Cdc6 is regulated by E2F and is essential for DNA replication in mammalian cells. Proc Natl Acad Sci USA 1998; 95: 3603-3608.
28. Suzuki-Takahashi I, Kitagawa M, Saijo M, et al. The interactions of E2F with pRB and with p107 are regulated via the phosphorylation of pRB and p107 by a cyclin-dependent kinase. Oncogene 1995; 10: 1691-1698.
29. Matsushime H, Ewen ME, Strom DK, et al. Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclins. Cell 1992; 71: 323-334.
30. Kato J, Matsushime H, Hiebert SW, Ewen ME, Sherr CJ. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev 1993; 7: 331-342.
31. Meyerson M, Harlow E. Identification of G1 kinase activity for cdk6, a novel cyclin D partner. Mol Cell Biol 1994; 14: 2077-2086.
32. Moroy T, Geisen C. Cyclin E. Int J Biochem Cell Biol 2004; 36: 1424-1439.
33. Hinds PW, Mittnacht S, Dulic V, et al. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 1992; 70: 993-1006.
34. Dynlacht BD, Flores O, Lees JA, Harlow E. Differential regulation of E2F transactivation by cyclin/cdk2 complexes. Genes Dev 1994; 8: 1772-1786.
35. Costa S, Blow JJ. The elusive determinants of replication origins. EMBO Rep 2007; 8: 332-334.
36. Speck C, Stillman B. Cdc6 ATPase activity regulates ORC-CDC6 stability and the selection of specific DNA sequences as origins of DNA replication. J Biol Chem 2007; 282: 11705-11714.
37. Wohlschlegel JA, Dwyer BT, Dhar SK, et al. Inhibition of eukaryotic DNA replication by Geminin binding to Cdt1. Science 2000; 290: 2309-2312.
38. Tada S, Li A, Maiorano D, Mechali M, Blow JJ. Repression of origin assembly in metaphase depends on inhibition of RLF-B/Cdt1 by Geminin. Nat Cell Biol 2001; 3: 107-113.
39. Nishitani H, Taraviras S, Lygerou Z, Nishimoto T. The human licensing factor for DNA replication Cdt1 accumulates in G1 and is destabilized after initiation of S-phase. J Biol Chem 2001; 276: 44905-44911.
40. Xouri G, Squire A, Dimaki M, et al. Cdt1 associates dynamically with chromatin throughout G1 and recruits Geminin onto chromatin. EMBO J 2007; 26: 1303-1314.
41. McGarry TJ, Kirschner MW. Geminin, an inhibitor of DNA replication, is degraded during mitosis. Cell 1998; 93: 1043-1053.
42. Bastians H, Topper LM, Gorbsky GL, Ruderman JV. Cell cycle-regulated proteolysis of mitotic target proteins. Mol Biol Cell 1999; 10: 3927-3941.
43. Luo L, Uerlings S, Happel N, et al. Regulation of Geminin functions by cell cycle dependent nuclear-cytoplasmic shuttling. Mol Cell Biol 2007; 27: 4737-4744.
44. Swanton C, Jones N. Strategies in subversion: deregulation of the mammalian cell cycle by viral gene products. Int J Exp Pathol 2001; 82: 3-13.
45. Salvant BS, Fortunato EA, Spector DH. Cell cycle dysregulation by human cytomegalovirus: influence of the cell cycle phase at the time of infection and effects on cyclin transcription. J Virol 1998; 72: 3729-3741.
46. Jault FM, Jault JM, Ruchti F, et al. Cytomegalovirus infection induces high levels of cyclins, phosphorylated Rb, and p53, leading to cell cycle arrest. J Virol 1995; 69: 6697-6704.
47. Hensel GM, Meyer HH, Buchmann I, et al. Intracellular localization and expression of the human cytomegalovirus matrix phosphoprotein pp71 (ppUL82): evidence for its translocation into the nucleus. J Gen Virol 1996; 77: 3087-3097.
48. Bresnahan WA, Shenk TE. UL82 virion protein activates expression of immediate early viral genes in human cytomegalovirus-infected cells. Proc Natl Acad Sci USA 2000; 97: 14506-14511.
49. Kalejta RF, Shenk T. The human cytomegalovirus UL82 gene product (pp71) accelerates progression through the G1 phase of the cell cycle. J Virol 2003; 77: 3451-3459.
50. Kalejta RF, Bechtel JT, Shenk T. Human cytomegalovirus pp71 stimulates cell cycle progression by inducing the proteasome-dependent degradation of the retinoblastoma family of tumor suppressors. Mol Cell Biol 2003; 23: 1885-1895.
51. Kalejta RF, Shenk T. Proteasome-dependent, ubiquitin-independent degradation of the Rb family of tumor suppressors by the human cytomegalovirus pp71 protein. Proc Natl Acad Sci USA 2003; 100: 3263-3268.
52. Winkler M, Stamminger T. A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles. J Virol 1996; 70: 8984-8987.
53. Winkler M, Rice SA, Stamminger T. UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J Virol 1994; 68: 3943-3954.
54. Lu M, Shenk T. Human cytomegalovirus UL69 protein induces cells to accumulate in G1 phase of the cell cycle. J Virol 1999; 73: 676-683.
55. Hayashi ML, Blankenship C, Shenk T. Human cytomegalovirus UL69 protein is required for efficient accumulation of infected cells in the G1 phase of the cell cycle. Proc Natl Acad Sci USA 2000; 97: 2692-2696.
56. Caswell R, Hagemeier C, Chiou CJ, et al. The human cytomegalovirus 86K immediate early (IE) 2 protein requires the basic region of the TATA-box binding protein (TBP) for binding, and interacts with TBP and transcription factor TFIIB via regions of IE2 required for transcriptional regulation. J Gen Virol 1993; 74: 2691-2698.
57. Hayhurst GP, Bryant LA, Caswell RC, Walker SM, Sinclair JH. CCAAT box-dependent activation of the TATA-less human DNA polymerase alpha promoter by the human cytomegalovirus 72-kilodalton major immediate-early protein. J Virol 1995; 69: 182-188.
58. Castillo JP, Kowalik TF. Human cytomegalovirus immediate early proteins and cell growth control. Gene 2002; 290: 19-34.
59. Pajovic S, Wong EL, Black AR, Azizkhan JC. Identification of a viral kinase that phosphorylates specific E2Fs and pocket proteins. Mol Cell Biol 1997; 17: 6459-6464.
60. Marchini A, Liu H, Zhu H. Human cytomegalovirus with IE-2 (UL122) deleted fails to express early lytic genes. J Virol 2001; 75: 1870-1878.
61. Mocarski ES, Kemble GW, Lyle JM, Greaves RF. A deletion mutant in the human cytomegalovirus gene encoding IE1(491aa) is replication defective due to a failure in autoregulation. Proc Natl Acad Sci USA 1996; 93: 11321-11326.
62. Greaves RF, Mocarski ES. Defective growth correlates with reduced accumulation of a viral DNA replication protein after low-multiplicity infection by a human cytomegalovirus iel mutant. J Virol 1998; 72: 366-379.
63. Poma EE, Kowalik TF, Zhu L, Sinclair JH, Huang ES. The human cytomegalovirus IE1-72 protein interacts with the cellular p107 protein and relieves p107-mediated transcriptional repression of an E2F-responsive promoter. J Virol 1996; 70: 7867-7877.
64. Hagemeier C, Caswell R, Hayhurst G, Sinclair J, Kouzarides T. Functional interaction between the HCMV IE2 transactivator and the retinoblastoma protein. EMBO J 1994; 13: 2897-2903.
65. Whyte P, Buchkovich KJ, Horowitz JM, et al. Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product. Nature 1988; 334: 124-129.
66. DeCaprio JA, Ludlow JW, Figge J, et al. SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene. Cell 1988; 54: 275-283.
67. Dyson N, Howley PM, Munger K, Harlow E. The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product. Science 1989; 243: 934-937.
68. Parker GA, Crook T, Bain M, et al. Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene 1996; 13: 2541-2549.
69. Margolis MJ, Pajovic S, Wong EL, et al. Interaction of the 72-kilodalton human cytomegalovirus IE1 gene product with E2F1 coincides with E2F-dependent activation of dihydrofolate reductase transcription. J Virol 1995; 69: 7759-7767.
70. Shan B, Lee WH. Deregulated expression of E2F-1 induces S-phase entry and leads to apoptosis. Mol Cell Biol 1994; 14: 8166-8173.
71. Tsai HL, Kou GH, Chen SC, Wu CW, Lin YS. Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J Biol Chem 1996; 271: 3534-3540.
72. Goldmacher VS, Bartle LM, Skaletskaya A, et al. A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2. Proc Natl Acad Sci USA 1999; 96: 12536-12541.
73. Chiou SH, Yang YP, Lin JC, et al. The immediate early 2 protein of human cytomegalovirus (HCMV) mediates the apoptotic control in HCMV retinitis through up-regulation of the cellular FLICE-inhibitory protein expression. J Immunol 2006; 177: 6199-6206.
74. Reeves MB, Davies AA, McSharry BP, et al. Complex 1 binding by a virally encoded RNA regulates mitochondria-induced cell death. Science 2007; 316: 1345-1348.
75. Andoniou CE, Degli-Esposti MA. Insights into the mechanisms of CMV-mediated interference with cellular apoptosis. Immunol Cell Biol 2006; 84: 99-106.
76. Bresnahan WA, Albrecht T, Thompson EA. The cyclin E promoter is activated by human cytomegalovirus 86-kDa immediate early protein. J Biol Chem 1998; 273: 22075-22082.
77. McElroy AK, Dwarakanath RS, Spector DH. Dysregulation of cyclin E gene expression in human cytomegalovirus-infected cells requires viral early gene expression and is associated with changes in the Rb-related protein p130. J Virol 2000; 74: 4192-4206.
78. Song YJ, Stinski MF. Effect of the human cytomegalovirus IE86 protein on expression of E2F-responsive genes: a DNA microarray analysis. Proc Natl Acad Sci USA 2002; 99: 2836-2841.
79. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 1993; 75: 805-816.
80. Sinclair J, Baillie J, Bryant L, Caswell R. Human cytomegalovirus mediates cell cycle progression through G(1) into early S phase in terminally differentiated cells. J Gen Virol 2000; 81: 1553-1565.
81. Chen Z, Knutson E, Kurosky A, Albrecht T. Degradation of p21cip1 in cells productively infected with human cytomegalovirus. J Virol 2001; 75: 3613-3625.
82. Weinshenker BG, Wilton S, Rice GP. Phorbol esterinduced differentiation permits productive human cytomegalovirus infection in a monocytic cell line. J Immunol 1988; 140: 1625-1631.
83. Gonczol E, Andrews PW, Plotkin SA. Cytomegalovirus replicates in differentiated but not in undifferentiated human embryonal carcinoma cells. Science 1984; 224: 159-161.
84. Lu M, Shenk T. Human cytomegalovirus infection inhibits cell cycle progression at multiple points, including the transition from G1 to S. J Virol 1996; 70: 8850-8857.
85. Bresnahan WA, Boldogh I, Thompson EA, Albrecht T. Human cytomegalovirus inhibits cellular DNA synthesis and arrests productively infected cells in late G1. Virology 1996; 224: 150-160.
86. Dittmer D, Mocarski ES. Human cytomegalovirus infection inhibits G1/S transition. J Virol 1997; 71: 1629-1634.
87. Murphy EA, Streblow DN, Nelson JA, Stinski MF. The human cytomegalovirus IE86 protein can block cell cycle progression after inducing transition into the S phase of permissive cells. J Virol 2000; 74: 7108-7118.
88. Wiebusch L, Asmar J, Uecker R, Hagemeier C. Human cytomegalovirus immediate-early protein 2 (IE2)-mediated activation of cyclin E is cell-cycle-independent and forces S-phase entry in IE2-arrested cells. J Gen Virol 2003; 84: 51-60.
89. Wiebusch L, Hagemeier C. The human cytomegalovirus immediate early 2 protein dissociates cellular DNA synthesis from cyclin-dependent kinase activation. EMBO J 2001; 20: 1086-1098.
90. Song YJ, Stinski MF. Inhibition of cell division by the human cytomegalovirus IE86 protein: role of the p53 pathway or cyclin-dependent kinase 1/cyclin B1. J Virol 2005; 79: 2597-2603.
91. Biswas N, Sanchez V, Spector DH. Human cytomegalovirus infection leads to accumulation of Geminin and inhibition of the licensing of cellular DNA replication. J Virol 2003; 77: 2369-2376.
92. Wiebusch L, Uecker R, Hagemeier C. Human cytomegalovirus prevents replication licensing by inhibiting MCM loading onto chromatin. EMBO Rep 2003; 4: 42-16.
93. Kuwahara K, Yoshida M, Kondo E, et al. A novel nuclear phosphoprotein, GANP, is up-regulated in centrocytes of the germinal center and associated with MCM3, a protein essential for DNA replication. Blood 2000; 95: 2321-2328.
94. Abe E, Kuwahara K, Yoshida M, et al. Structure, expression, and chromosomal localization of the human gene encoding a germinal center-associated nuclear protein (GANP) that associates with MCM3 involved in the initiation of DNA replication. Gene 2000; 255: 219-227.
95. Takei Y, Swietlik M, Tanoue A, et al. MCM3AP, a novel acetyltransferase that acetylates replication protein MCM3. EMBO Rep 2001; 2: 119-123.
96. Takei Y, Assenberg M, Tsujimoto G, Laskey R. The MCM3 acetylase MCM3AP inhibits initiation, but not elongation, of DNA replication via interaction with MCM3. J Biol Chem 2002; 277: 43121-43125.
97. Pari GS, Anders DG. Eleven loci encoding trans-acting factors are required for transient complementation of human cytomegalovirus oriLyt-dependent DNA replication. J Virol 1993; 67: 6979-6988.
98. Smith JA, Pari GS. Human cytomegalovirus UL102 gene. J Virol 1995; 69: 1734-1740.
99. Smith JA, Jairath S, Crute JJ, Pari GS. Characterization of the human cytomegalovirus UL105 gene and identification of the putative helicase protein. Virology 1996; 220: 251-255.
100. McMahon TP, Anders DG. Interactions between human cytomegalovirus helicase-primase proteins. Virus Res 2002; 86: 39-52.